|
000
| 01612cam 2200289za 4500 |
|---|
| 001 | 9.847426 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107153435 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 171120s2018 onca o f000 0 eng d |
|---|
| 020 | |a9780660239132|z9780660239149 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aNR16-171/2017E-PDF |
|---|
| 110 | 2 |aNational Research Council Canada. |
|---|
| 245 | 10|aADAPT platform for antibody affinity maturation (T-90201) |h[electronic resource]. |
|---|
| 260 | |a[Ottawa] : |bNational Research Council Canada, |c[2018] |
|---|
| 300 | |a[2] p. : |bcol. ill. |
|---|
| 500 | |aIssued also in French under title: Plateforme ADAPT pour la maturation de l’affinité des anticorps (T-90201). |
|---|
| 500 | |aCaption title. |
|---|
| 500 | |a"December 2017." |
|---|
| 520 | |a“To aid in the selection and rationalization of mutants that improve and/or modulate the affinity of antibodies and other biologics, the NRC has developed an efficient platform called ADAPT (Assisted Design of Antibody and Protein Therapeutics). ADAPT interleaves computational predictions with experimental validation, significantly aiding the design of protein therapeutics by guiding the selection of optimal mutations”--Highlights, p. [1]. |
|---|
| 530 | |aIssued also in print format. |
|---|
| 693 | 4|aImmunotechnology |
|---|
| 775 | 08|tPlateforme ADAPT pour la maturation de l’affinité des anticorps (T-90201) |w(CaOODSP)9.847428 |
|---|
| 776 | 0#|tADAPT platform for antibody affinity maturation |w(CaOODSP)9.847427 |
|---|
| 856 | 40|qPDF|s204 KB|uhttps://publications.gc.ca/collections/collection_2018/cnrc-nrc/NR16-171-2017-eng.pdf |
|---|